Prurigo Nodularis Drugs Market
According to report by IMARC Group, the report provides the key factors driving the advancement in treatment of Prurigo Nodularis. The increasing prevalence of pruritus that can be triggered by various underlying conditions, such as eczema, insect bites, skin inflammation, etc., is primarily driving the market.